Location History:
- Galveston, TX (US) (2011)
- Pearland, TX (US) (2014)
- Galyeston, TX (US) (2015)
- Houston, TX (US) (2017 - 2020)
Company Filing History:
7 out of 5,506 
3 out of 596 
1 out of 22 
Years Active: 2011-2020
Title: Scott R Gilbertson: Innovator in Pharmaceutical Research
Introduction
Scott R Gilbertson is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceutical research, holding a total of 8 patents. His work primarily focuses on developing innovative treatments for various diseases.
Latest Patents
Among his latest patents, Gilbertson has developed novel analogs of selective 5HTR agonist WAY163909. This invention relates to the preparation and use of these analogs, which have potential therapeutic applications. Additionally, he has created peptide inhibitors of Rho-associated kinase (ROCK), which are aimed at treating disorders such as heart failure. This invention highlights a new class of inhibitory drugs that could be beneficial in managing several critical health conditions, including heart disease and stroke.
Career Highlights
Gilbertson has worked with prestigious institutions, including the University of Texas System and the University of Houston System. His research has significantly impacted the understanding and treatment of various diseases, showcasing his dedication to advancing medical science.
Collaborations
Throughout his career, Gilbertson has collaborated with esteemed colleagues, including Kathryn A Cunningham and Vladimir L Motin. These partnerships have further enriched his research and innovation efforts.
Conclusion
Scott R Gilbertson stands out as a prominent inventor in the pharmaceutical field, with a focus on developing innovative treatments for serious health conditions. His contributions continue to influence the landscape of medical research and innovation.